glp-1 agonists medications New Guidelines for Type 2 Diabetes in 2025 GLP-1 Medications for Weight Loss:
Description
Wei G, Lu K, Umar M, et al
Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation
"Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)." New England Journal of Medicine , 384(11):989-1002
And they must be refrigerated until use
For research use only
Not for use in patients with type 1 diabetes or diabetic ketoacidosis
